November 15, 2026
1 min read

Earnings Beat Could Be A Big Moment For Abbott Stock And Nutrition Split Plans

Abbott Laboratories reported stronger third quarter 2026 sales and earnings across key segments and outlined plans to spin off its global Nutrition business into a separate public company by the end of 2027.
The company also highlighted progress in its medical devices pipeline, including positive data for the Amulet 360 LAA Occluder and SonicForce Coronary IVL System, reinforcing the role of new products alongside the Nutrition separation.
Next, the focus shifts to how Abbott Laboratories’…

Leave a Reply

Your email address will not be published.

Previous Story

Rapid Food Composition Assessment Must Integrate Bioavailability to Determine Human Nutritional Adequacy

Next Story

Are Pumpkin Seeds Healthier Than Chia Seeds? Nutritionists Weigh In

Previous Story

Rapid Food Composition Assessment Must Integrate Bioavailability to Determine Human Nutritional Adequacy

Next Story

Are Pumpkin Seeds Healthier Than Chia Seeds? Nutritionists Weigh In

Latest from Blog

Go toTop